Skip to main content
. 2023 Oct 13;10(10):1188. doi: 10.3390/bioengineering10101188

Figure 4.

Figure 4

(A) Effect of minicellsazurin on the migration of CT26/HT29 colon cancer cells. (B) Mouse CT26 colon cancer cells and human HT29 colon cancer cells migration toward a chemoattractant (culture media supplemented with FBS) was evaluated in Transwell assays. Cells were treated with CM from minicells, minicellsazurin, and cancer cell media (culture media control) for 24 h, and cell migration was quantified. Results are presented as the percentage of invasive cells compared to the control condition (p-values compare % of cancer cell invasiveness between minicellsazurin CM treatment and the remaining treatment conditions; n = 3). (C) Effect of minicellsazurin on the invasion of CT26/HT29 colon cancer cells. (D) Human HT29 colon cancer cells and mouse CT26 colon cancer cells invasion toward a chemoattractant (culture media supplemented with FBS) was evaluated in Matrigel invasion assays. Cells were treated with CM from minicells, minicellsazurin, and cancer cell media (culture media control) for 24 h, and cell migration was quantified. Results are presented as the percentage of invasive cells compared to the control condition (p-values compare % of cancer cell invasiveness between minicellsazurin’ CM treatment and the remaining treatment conditions; n = 3). The significance was determined by a ONE-WAY ANOVA (*** p < 0.001, ** p < 0.01, * p < 0.05, ns: no significance).